Click on their name to send an email.
Claudia Hopenhayn, MPH,Ph.D.
859-219-0773 ext. 307
Dr. Claudia Hopenhayn is an associate professor in the Department of Epidemiology, College of Public Health, University of Kentucky. She is also senior epidemiologist in the Markey Cancer Control Program. Dr. Hopenhayn holds an MPH in epidemiology/biostatistics and a PhD in Epidemiology, both form the School of Public Health, University of California, Berkeley.
Dr. Hopenhayn’s roles in the College of Public Health include teaching graduate level courses in epidemiology, advising and mentoring graduate students for their capstones, practicum experiences and dissertations; serving on a number of different faculty committees: currently on the Faculty Council and APT committees, and chairing the Global Health committee which is developing a new graduate certificate program in global health. She also participates in an ongoing project in Ecuador, involving primary care and public health service and research. Dr. Hopenhayn co-leads summer trips of students, faculty and community members to Santo Domingo de los Colorados in Ecuador. This growing effort includes participation and travel of several CPH students every year.
Dr. Hopenhayn has been a member of several national and international committees and panels. Current or recent ones include the External Scientific Advisory Board of the University of Arizona’s Superfund Basic Research Program; the EPA’s Scientific Advisory Board on Arsenic Health Effects, and the Institute of Medicine’s Health Effects in Vietnam Veterans of Exposure to Herbicides (Agent Orange). Aside from presenting yearly at various conferences and venues, Dr. Hopenhayn is a peer reviewer for over 10 scientific journals, and publishes in Epidemiology, Environmental Health Perspectives, Environmental Research, International Journal of Epidemiology, Cancer Causes and Control, among others.
Dr. Hopenhayn’s primary research interests have focused on cancer and reproductive outcomes, within the context of environmental and occupational exposures and cancer control, and on global health issues. She is an expert on the epidemiology of arsenic from drinking water, having participated in several multidisciplinary international projects, including short term assignments with the World Health Organization and as principal investigator of a large, multidisciplinary pregnancy cohort study in Chile.
Dr. Hopenhayn has also conducted epidemiologic research in Kentucky, in the fields of colorectal, ovarian, cervical and lung cancer, linking data from the Kentucky Cancer Registry, tumor biomarkers, environmental exposures and behavioral risk factors. She is currently directing a study investigating the clinical, behavioral and institutional factors associated with survival of early stage lung cancer, and is the Kentucky lead in a multi-state, population-based study of cervical cancer and HPV-typing.